Status:

UNKNOWN

Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer

Lead Sponsor:

Institut Cancerologie de l'Ouest

Conditions:

Adenocarcinoma

Pancreatic Cancer Metastatic

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Adenocarcinoma of the pancreas is a major public health issue because of its disastrous prognosis. The symptomatology of locally advanced or metastatic forms, particularly painful, is often major and ...

Eligibility Criteria

Inclusion

  • Patient ≥ 18 years old ;
  • Patient with histologically or cytologically proven locally advanced and/or metastatic adenocarcinoma of the pancreas;
  • Patient undergoing or failing medical treatment and comfort care only;
  • Patient with EVA ≥ 4 and/or requiring analgesics level 3;
  • Performans Status (ECOG) \< 3 ;
  • Informing the patient and obtaining free, informed and written consent signed by the patient and the investigator;
  • Patient affiliated or beneficiary of the social security system

Exclusion

  • Patient does not have a smartphone, tablet or computer;
  • Patient with no personal internet access at home (WIFI, wired), or via his smartphone;
  • Patient does not feel able to fill out an electronic questionnaire;
  • Patient cannot read or write French;
  • Patient does not speak and understand French;
  • Persons deprived of liberty or under guardianship or trusteeship ;
  • Dementia, mental alteration or psychiatric pathology that could compromise the patient's informed consent and/or compliance with the protocol and follow-up of the trial ;
  • Inability to submit to trial protocol follow-up for geographical, social, or other reasons ;
  • Patient participating in another interventional study evaluating treatment and pain management.

Key Trial Info

Start Date :

February 7 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 8 2024

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04667403

Start Date

February 7 2022

End Date

February 8 2024

Last Update

April 28 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ICO site St HERBLAIN

Saint-Herblain, France, 44805